News

Alzheimer’s disease is a serious condition that mostly affects older people. It causes memory loss, confusion, and changes in how a person thinks and behaves. It’s the most common cause of dementia, a ...
Tiziana (TLSA) is showing groundbreaking advancements in Alzheimer's & MS treatments with foralumab. Key trials & market ...
"The scale at which we analyzed the amyloid peptides was unprecedented," said Ben Lehner of the Wellcome Sanger Institute.
In patients showing cognitive decline, a new blood test for Alzheimer's is expected to make diagnosis more convenient, ...
By analyzing thousands of Aβ42 peptides, the scientists gained a better understanding of how mutations in Aβ affect protein ...
Inspired by advances in cancer therapy, a team at the Buck Institute has engineered immune cells equipped with specialized ...
Taking inspiration from the CAR T-cell technology used to provide personalized cancer treatments, researchers have conducted ...
A new large-scale study has mapped the first molecular events that drive the formation of harmful amyloid protein aggregates ...
A new large-scale study has mapped the first molecular events that drive the formation of harmful amyloid protein aggregates ...